A cost-utility study of the use of pregabalin added to usual care in refractory neuropathic pain patients in a Swedish setting.
about
Add-on treatment with pregabalin for patients with uncontrolled neuropathic pain who have been referred to pain clinicsPregabalin in neuropathic pain: evidences and possible mechanisms.Pharmacoeconomic outcomes for pregabalin: a systematic review in neuropathic pain, generalized anxiety disorder, and epilepsy from a Spanish perspective.When to use discrete event simulation (DES) for the economic evaluation of health technologies? A review and critique of the costs and benefits of DES.A systematic review of cost-effectiveness modeling of pharmaceutical therapies in neuropathic pain: variation in practice, key challenges, and recommendations for the future.Cost-effectiveness analysis of pregabalin for treatment of chronic low back pain in patients with accompanying lower limb pain (neuropathic component) in Japan.
P2860
A cost-utility study of the use of pregabalin added to usual care in refractory neuropathic pain patients in a Swedish setting.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
A cost-utility study of the us ...... patients in a Swedish setting.
@en
A cost-utility study of the us ...... patients in a Swedish setting.
@nl
type
label
A cost-utility study of the us ...... patients in a Swedish setting.
@en
A cost-utility study of the us ...... patients in a Swedish setting.
@nl
prefLabel
A cost-utility study of the us ...... patients in a Swedish setting.
@en
A cost-utility study of the us ...... patients in a Swedish setting.
@nl
P2093
P1476
A cost-utility study of the us ...... patients in a Swedish setting.
@en
P2093
Jan-Rickard Norrefalk
Matthew Prettyjohns
Rebecka Sandelin
Steven Lister
P304
P356
10.3111/13696998.2012.704458
P407
P577
2012-07-05T00:00:00Z